Real-world analysis of medication adherence and cost of care for comorbid conditions in patients with early Alzheimer’s disease in the U.S.
Patients with early AD had multiple comorbidities and took multiple medications. Suboptimal medication adherence and high healthcare costs were observed.
Authors
- Abdalla Aly (ORCID: https://orcid.org/0000-0001-7411-894X)
- Soeren Mattke (ORCID: https://orcid.org/0000-0003-4666-9132)
- Shannon Gallagher (ORCID: https://orcid.org/0000-0003-1114-3851)
- Caroline McKay
- Kristian Garcia
- Lei Lv (ORCID: https://orcid.org/0009-0008-1160-0673)
- Heather E. Moss (ORCID: https://orcid.org/0000-0003-4373-447X)
- Paul Mystkowski
Institutions
- University of Southern California (US)
- Verizon (United States) (US)
- California Southern University (US)
- Novo Nordisk (United States) (US)
- Novo Nordisk (United Kingdom) (GB)
- Stanford University (US)
Publication Details
- Journal
- Neurodegenerative Disease Management
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1080/17582024.2025.2590936
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 0.00